Malignant mesothelioma is characterized by its association with asbestos, its long latency
period, and the propensity for the diagnosis to be obtained in the later stages of the disease …

Although the insulating properties of asbestos have been known for millennia, the link
between asbestos exposure and mesothelioma was not recognized until 1960, when it was …

Malignant pleural mesothelioma (MPM) is a rare tumor with a generally poor prognosis,
mainly associated with earlier occupational exposure to asbestos. In Western industrialized …

Purpose: We established a screening program for prior asbestos workers using low-dose
computed tomography (LDCT). Methods: Between March 2005 and October 2007 we …

Introduction Malignant pleural mesothelioma (MPM) is a lethal tumor related to asbestos
exposure. At present, the only instruments for screening and diagnosis are based on …

Malignant mesotheliomas have assumed an importance in the medical and lay literature out
of proportion to their incidence in the American population, chiefly due to the known …

Malignant mesothelioma has a very dismal prognosis with very few patients surviving one
year after diagnosis. Early multimodal treatment, however, is expected to improve the …

Introduction There is increasing interest in identifying a blood-based marker for the asbestos-
related tumor, malignant mesothelioma. Three potential markers for mesothelioma are …

Diffuse malignant mesothelioma (MM) is the most common primary tumour of the pleura, and
also occurs less frequently in the peritoneum (6–10%), pericardium, tunica vaginalis and …

Background: Soluble mesothelin-related peptides (SMRP) have been reported to be
potential biomarkers for malignant pleural mesothelioma (MPM). We report analytical and …